Clinical Trial Update: Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNA

View source ↗

Summary

This completed clinical trial assesses how varying concentrations of Sofosbuvir and Daclatasvir influence Hepatitis C RNA levels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hepatitis C | Status: COMPLETED